HomeCompareATRWF vs JNJ

ATRWF vs JNJ: Dividend Comparison 2026

ATRWF yields 23.53% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ATRWF wins by $60.2K in total portfolio value
10 years
ATRWF
ATRWF
● Live price
23.53%
Share price
$8.50
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$90.5K
Annual income
$9,663.72
Full ATRWF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — ATRWF vs JNJ

📍 ATRWF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodATRWFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ATRWF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ATRWF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ATRWF
Annual income on $10K today (after 15% tax)
$2,000.00/yr
After 10yr DRIP, annual income (after tax)
$8,214.16/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, ATRWF beats the other by $4,228.17/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ATRWF + JNJ for your $10,000?

ATRWF: 50%JNJ: 50%
100% JNJ50/50100% ATRWF
Portfolio after 10yr
$60.4K
Annual income
$7,176.56/yr
Blended yield
11.89%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ATRWF
Analyst Ratings
1
Sell
Consensus: Sell
Altman Z
14.7
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ATRWF buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricATRWFJNJ
Forward yield23.53%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$90.5K$30.3K
Annual income after 10y$9,663.72$4,689.40
Total dividends collected$55.7K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusSellBuy

Year-by-year: ATRWF vs JNJ ($10,000, DRIP)

YearATRWF PortfolioATRWF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$13,053$2,352.94$10,592$272.30+$2.5KATRWF
2$16,837$2,870.36$11,289$357.73+$5.5KATRWF
3$21,476$3,460.26$12,123$472.89+$9.4KATRWF
4$27,104$4,124.87$13,141$629.86+$14.0KATRWF
5$33,867$4,865.30$14,408$846.81+$19.5KATRWF
6$41,919$5,681.51$16,021$1,151.60+$25.9KATRWF
7$51,425$6,572.30$18,122$1,588.22+$33.3KATRWF
8$62,561$7,535.33$20,930$2,228.20+$41.6KATRWF
9$75,507$8,567.24$24,792$3,191.91+$50.7KATRWF
10$90,456$9,663.72$30,274$4,689.40+$60.2KATRWF

ATRWF vs JNJ: Complete Analysis 2026

ATRWFStock

Altius Renewable Royalties Corp., a renewable energy royalty company, engages in the acquisition and management of renewable energy investments and royalties in North America. It also provides tailored financing solutions to the renewable power sector. The company holds interests in a portfolio of 695 MW of wind, hydro-electric, and solar energy projects located in Texas, Kansas, and Vermont, as well as royalty interests in a portfolio of 2,845 MW of development stage wind energy projects located in Texas, Indiana, and Illinois. It serves renewable power developers, operators, and originators. The company was incorporated in 2018 and is headquartered in St. John's, Canada. Altius Renewable Royalties Corp. is a subsidiary of Altius Minerals Corporation.

Full ATRWF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this ATRWF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ATRWF vs SCHDATRWF vs JEPIATRWF vs OATRWF vs KOATRWF vs MAINATRWF vs ABBVATRWF vs MRKATRWF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.